Valentis Group
Introduction
Valentis Group is firmly committed to upholding human rights and preventing all forms of modern slavery, human trafficking, forced labour, and child labour within our organization and across our supply chains.
This statement outlines the measures we take to ensure compliance with international laws and ethical practices, in line with the UK Modern Slavery Act 2015 and other similar legislation in jurisdictions where we operate.
Company Overview
Valentis Group is an international healthcare company active in the licensing, marketing, sales, and supply of pharmaceutical products, diagnostic solutions, and clinical trial materials. With operations in Türkiye, Germany, Switzerland, and the UAE, we recognize our responsibility to uphold ethical practices in every country we work in.
Our Commitment
We unequivocally oppose all forms of:
We expect all Valentis employees, partners, and suppliers to respect and align with internationally recognized human rights principles, including the UN Guiding Principles on Business and Human Rights and ILO Conventions.
Risk Assessment and Due Diligence
We evaluate ethical and human rights risks in our supply chains by:
Supplier Standards and Preventive Measures
Our expectations from suppliers are clearly defined through:
Where necessary, we reserve the right to audit suppliers or request supporting documentation.
Training and Awareness
While Valentis does not currently provide external consultancy, we ensure that our internal teams involved in procurement and partner evaluation are:
Reporting and Grievance Mechanisms
We provide secure and confidential channels to report:
All reports are investigated promptly and fairly. Appropriate action is taken when violations are identified.
Reports can be submitted via: bilgi@valentis.com.tr
Governance and Continuous Improvement
This policy is reviewed and approved annually by Valentis Group senior management.
We are committed to continuously improving our policies and procedures to better detect, prevent, and respond to ethical risks ensuring alignment with evolving global expectations.
Signed:
Selçuk Güler
Founder & CEO
Date: November, 2025